1. Toll-interacting protein may affect doxorubicin resistance in hepatocellular carcinoma cell lines
   Ayse Banu Demir et al, 2023, Molecular Biology Reports CrossRef
2. Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis
   Yusuke Kawamura et al, 2020, Liver Cancer CrossRef
3. Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile
   Ilse R. Dubbelboer et al, 2019, Cancers CrossRef
4. Nanotechnology in the Diagnostic and Therapy of Hepatocellular Carcinoma
   Florin Graur et al, 2022, Materials CrossRef
5. Tumor-Suppressor Role of the α1-Na/K-ATPase Signalosome in NASH Related Hepatocellular Carcinoma
   Utibe-Abasi S. Udoh et al, 2022, International Journal of Molecular Sciences CrossRef
6. High throughput direct 3D bioprinting in multiwell plates
   Henry H Hwang et al, 2021, Biofabrication CrossRef